
An allergy-and-itch video sends visitors to a five-reason sales story for the matching chew. The destination redirects to the brand’s dedicated campaign domain. Compare the creative with the destination and explore the other ads sharing this route.
Selected for its design and offer structure. Ad performance isn’t available in this collection.
The hand-drawn format is memorable and easy to follow: each symptom gets its own illustration, circled in red as the voiceover names it, so the viewer watches a lesson build on paper. The structure is a numbered list (five symptoms, five ingredients), which makes a complicated product feel organized and gives owners a symptom to recognize in their own dog. Ending on one chew that, in the ad's words, combines all five is a clean wrap-up. The headline, a 2-second routine, makes daily use sound effortless, and the link description adds the 90-day risk-free trial.
Each symptom is paired with an ingredient and a confident claim (quercetin blocks the urge to scratch, vitamin E clears up discharge), and none of those claims come with a source or proof in the ad. That's a lot of promising for a pet supplement, and a skeptical owner will notice. If you make one like this, keep the drawing format and the numbered list, but soften each line to what the ingredient is included for, add a source footnote, and close on a real owner's before and after.
A numbered promise tells the viewer exactly what they'll learn.
Owners see the behaviors they recognize first, which keeps them watching.
Each ingredient gets a job, which makes the formula feel explained rather than listed.
It collects all five into one product and gives a time-limited reason to act.
A 90-day risk-free trial while it's on sale, repeated in the link description. The input notes 25% off plus free shipping on the page at capture, and the link path reads SAVE57%.
The ad links to the five-reason allergy listicle, an advertorial with an expert byline that fits a video already built as a lesson. Reason three continues the ingredient story with five ingredient rows, each with an icon, name and amount, so the viewer can check what the video named. The why-this-over-alternatives section and reason four's timeline (first week, first month, three months) add context the video skips. The offer card's risk-free CTA and guarantee lines pick up the 90-day trial from the ad.
Wuffes' allergy page is a five-reason listicle advertorial with a veterinarian byline. A why-this-over-alternatives section comes before the reasons, which cover benefits, customer proof, ingredients, a timeline and quality, ending on one offer card and a sticky discount bar. Three ads in the Fluid library send people here, all problem-led videos about itching and licking.
A sale headline with a discount-and-shipping line and a countdown timer answers is there a deal right now.
The listicle headline, an expert byline with headshot and updated date, an intro and a photo of the dog with jars answer who's writing and what's this about.
Copy contrasting usual remedies with the product's approach, beside a dog illustration, answers why would this work when other things didn't.
A grid of check-mark pill tags listing benefit areas answers what does it claim to address.
A customer-count heading, first-person expert copy and a carousel of verified review cards answer do other owners vouch for it.
Five ingredient rows with icons, names and amounts answer what's in it.
A before and after photo and three milestone blocks with “most users noticed” notes answer how long will it take.
Quality copy with bolded claims beside a photo of the dog being fed and certification icons answers is it made to a high standard.
A Best-Seller card with a rating, three bullets, a risk-free button naming the discount and guarantee and shipping lines answers what's the deal and the risk.
Disclaimers and a sticky bar with the discount line, rating and apply-discount button keep the offer in reach.
Read the full breakdown of this page
One of 8 Wuffes ads in the Fluid Inspiration Library, captured from the Meta Ad Library on Oct 19, 2026. We record that an ad ran publicly, not how it performed.